Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of ...
SurvivorNet on MSN
Could timing give your cancer treatment a boost? New study on the best time to receive immunotherapy & chemo for non-small cell lung cancer
A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...
Explore new findings on drug-resistant breast cancer and how targeting cell cycle regulators may improve treatment outcomes.
SurvivorNet on MSN
More control, better quality of life: What to know about tarlatamab, the new immunotherapy drug approved for small-cell lung cancer
Tarlatamab (Imdelltra) is a new type of immunotherapy approved for people with small-cell lung cancer whose disease has progressed after chemotherapy and immunotherapy.
News-Medical.Net on MSN
Super-enhancers: Cancer's double-edged sword of growth and DNA damage
New study shows that cancer damages its own DNA by pushing key genes to work too hard. Researchers found that the most powerful genetic "on switches" in cancer cells, called super-enhancers, drive ...
A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.
1d
Review by Indian researchers notes that body’s immune cells ‘betray’ it to help breast cancer spread
Indian researchers reveal how immune cells 'betray' the body, aiding breast cancer spread and suggesting new treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results